Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2606
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure ; day:22 ; month:2 ; year:2021 ; pages:1-18
Reviews in endocrine & metabolic disorders ; (22.2.2021), 1-18
- Creator
-
Gencer, Baris
Bonomi, Marco
Adorni, Maria Pia
Sirtori, Cesare R.
Mach, François
Ruscica, Massimiliano
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11154-021-09628-2
- URN
-
urn:nbn:de:101:1-2021041006434039256952
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gencer, Baris
- Bonomi, Marco
- Adorni, Maria Pia
- Sirtori, Cesare R.
- Mach, François
- Ruscica, Massimiliano
- SpringerLink (Online service)
Other Objects (12)
Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
High density lipoprotein mimicking nanoparticles for atherosclerosis
Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity
Subclinical heart failure in juvenile idiopathic arthritis: a consequence of chronic inflammation and subclinical atherosclerosis
Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
High density lipoprotein mimicking nanoparticles for atherosclerosis
Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity
Subclinical heart failure in juvenile idiopathic arthritis: a consequence of chronic inflammation and subclinical atherosclerosis
Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis
P01-014 – Subclinical atherosclerosis in FMF
Predictors of subclinical atherosclerosis in HIV
Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes
Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study
Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
High density lipoprotein mimicking nanoparticles for atherosclerosis
Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Contribution of Type 2 Diabetes Mellitus to Subclinical Atherosclerosis in Subjects with Morbid Obesity